LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
LKFT
38 hedge funds and large institutions have $543M invested in Lakefront Biotherapeutics American Depositary Shares in 2016 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
19% more funds holding
Funds holding: 32 → 38 (+6)
Holders
38
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$16.8M | |
| 2 | +$9.69M | |
| 3 | +$6.56M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$6.42M |
| 5 |
O
OrbiMed
New York
|
+$6.17M |
Top Sellers
| 1 | -$2.5M | |
| 2 | -$2.19M | |
| 3 | -$1.96M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.64M |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$547K |